Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $112.17 million. The enterprise value is $111.80 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIST has 66.37 million shares outstanding. The number of shares has increased by 47.93% in one year.
| Current Share Class | 53.46M |
| Shares Outstanding | 66.37M |
| Shares Change (YoY) | +47.93% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 3.79% |
| Owned by Institutions (%) | 21.60% |
| Float | 50.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.67
| Current Ratio | 4.67 |
| Quick Ratio | 4.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.31 |
Financial Efficiency
Return on equity (ROE) is -307.27% and return on invested capital (ROIC) is -45.94%.
| Return on Equity (ROE) | -307.27% |
| Return on Assets (ROA) | -41.29% |
| Return on Invested Capital (ROIC) | -45.94% |
| Return on Capital Employed (ROCE) | -106.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.57M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.67% in the last 52 weeks. The beta is 0.86, so MIST's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +12.67% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.64 |
| Relative Strength Index (RSI) | 66.63 |
| Average Volume (20 Days) | 947,150 |
Short Selling Information
The latest short interest is 1.97 million, so 2.96% of the outstanding shares have been sold short.
| Short Interest | 1.97M |
| Short Previous Month | 2.37M |
| Short % of Shares Out | 2.96% |
| Short % of Float | 3.86% |
| Short Ratio (days to cover) | 1.29 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.15M |
| Pretax Income | -48.41M |
| Net Income | -51.93M |
| EBITDA | -52.05M |
| EBIT | -52.15M |
| Earnings Per Share (EPS) | -$0.78 |
Full Income StatementBalance Sheet
The company has $55.96 million in cash and $55.59 million in debt, giving a net cash position of $371,000 or $0.01 per share.
| Cash & Cash Equivalents | 55.96M |
| Total Debt | 55.59M |
| Net Cash | 371,000 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | -6.12M |
| Book Value Per Share | -0.09 |
| Working Capital | 47.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.87 million and capital expenditures -$39,000, giving a free cash flow of -$33.91 million.
| Operating Cash Flow | -33.87M |
| Capital Expenditures | -39,000 |
| Free Cash Flow | -33.91M |
| FCF Per Share | -$0.51 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |